Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Hartwig Piepenbrock-DZNE Prize: EUR 100,000 for brain researchers

11.09.2013
Prof. Adriano Aguzzi of the University of Zurich and Prof. Charles Weissmann of the Scripps Research Institute Florida (USA) will be awarded the 2013 “Hartwig Piepenbrock-DZNE Prize” for outstanding research in the field of neurodegenerative diseases.

Aguzzi’s and Weissmann’s groundbreaking discoveries on the mechanisms underlying prion diseases have major implications for the understanding of other neurodegenerative conditions, including Alzheimer’s and Parkinson’s disease. The prize is awarded by the Piepenbrock Group and the German Center for Neurodegenerative Diseases (DZNE). The award ceremony will be held in Berlin on September 24, 2013.

This year the Hartwig Piepenbrock-DZNE prize has a special significance. It marks the company's 100th anniversary and therefore honors the two winners with 100,000 Euro. But 2013 is also the year where special remembrance is given to Hartwig Piepenbrock who forged this company into one of the largest German family firms. He was diagnosed with dementia several years ago and died on July 3. For many years, he was a great benefactor of the arts, science and society. The prize, sponsored by the Piepenbrock Group, recognizes the outstanding research achievements of Profs. Weissmann and Aguzzi. The winners have been selected by an international panel including highly recognized scientists and representatives from the DZNE and the Piepenbrock family.

"The outstanding scientific contributions of Charles Weissmann and Adriano Aguzzi are of extraordinary importance for the entire research field of neurodegenerative diseases," comments Prof. Johannes Dichgans, chairman of the selection committee. "With their prion research they have unveiled previously unknown mechanisms that are crucial for many of these diseases, including Alzheimer’s disease and Parkinson’s disease”. A fundamental aspect of these mechanisms is the accumulation of endogenous, misfolded proteins. The work of Aguzzi and Weissmann provides a solid basis to design new strategies for early diagnosis as well as effective prevention and therapy.

The initial work from Weissmann and Aguzzi provided the most convincing evidence that in prion diseases like BSE or Creutzfeld-Jakob disease an endogenous protein is of central importance. They showed that infective material causes nerve cell death only if this particular protein is present. In subsequent work, the research teams led by Aguzzi and Weissmann clarified fundamental mechanisms by which misfolded proteins, such as prions, could cause toxicity. Work from the Weissmann lab has led to the development of new assays for prion replication and toxicity, as well as characterizing sources of infectivity in humans. Aguzzi and his team went on to reveal how prions propagate from cell to cell and finally invade the brain.

Accumulation of endogenous, misfolded proteins is also at the core of other neurodegenerative disorders including Alzheimer's and Parkinson's diseases. Although the cause of misfolded protein accumulation is not an infection as in some prion diseases, the spread of these proteins from cell to cell and within the nervous system seem to follow similar patterns. There is no evidence that other neurodegenerative diseases such as Alzheimer’s or Parkinson’s disease are contagious. The similarity in the underlying mechanisms of disease progression raises common fundamental research questions and suggests future approaches for prevention, diagnosis and therapy.

The Honorees

Prof. Charles Weissmann (born in 1931) is a Professor Emeritus at the Scripps Research Institute in Florida (USA). The Swiss molecular biologist studied medicine in Zurich and obtained his doctorate in organic chemistry. He completed a postdoctoral fellowship at the School of Medicine of the New York University and subsequently joined the faculty there. In 1967, he returned to the University of Zurich where he assumed the position of Director of the Institute for Molecular Biology. In 1999 he accepted a position with the MRC Prion Unit at the University College London. Five years later he was appointed to the new Scripps Research Institute Florida, where he established and directed the Institute for Infectiology for eight years. Website: http://www.scripps.edu/florida/research/faculty/weissmann

Prof. Adriano Aguzzi (born in 1960) was appointed Director of the Swiss National Reference Center for Prion Diseases at the end of 1995 and has been the Director and a member of the faculty of the Institute for Neuropathology at the University of Zurich since 1997. He obtained his medical degrees in Fribourg and Basel. Following periods at Columbia University, the University of Zurich and the Research Institute for Molecular Pathology in Vienna, he has held the position of Medical Director and Private Lecturer in the fields of pathology and neuropathology at the University of Zurich since 1993. Aguzzi is a citizen of both, Italy and Switzerland. Website: http://www.neuroscience.ethz.ch/research/aging_disorders/aguzzi

About Piepenbrock
The Piepenbrock Group is a fourth generation owner-operated family business. Piepenbrock offers a broad spectrum of services to its customers in the fields of facility management, commercial janitorial services, security and maintenance. Piepenbrock is also a successful packaging machine engineering enterprise. Piepenbrock has a long-established tradition of advocating for the environment, the arts and sports. Aware of the severe impact that neurodegenerative diseases impose on patients, families and caretakers, the Piepenbrock Group has decided to extend their social engagement to the research on neurodegenerative diseases by supporting this research award.
More information:
http://www.piepenbrock.de
http://www.twitter.com/piepenbrock_ug
http://www.youtube.com/user/piepenbrockservice
http://www.xing.com/companies/piepenbrock
About DZNE
The German Center for Neurodegenerative Diseases (DZNE) conducts research into the causes of diseases of the nervous system and develops preventive, therapeutic and care strategies. It is an institute within the Helmholtz Association of German Research Centers with sites in Berlin, Bonn, Dresden, Göttingen, Magdeburg, Munich, Rostock/Greifswald, Tübingen and Witten. The DZNE works in close cooperation with universities, university clinics and non-university research institutions. Website: www.dzne.de / Twitter: http://twitter.com/DZNE_de

Dr. Marcus Neitzert | idw
Further information:
http://www.dzne.de/en/about-us/public-relations/meldungen/2013/press-release-no-26.html

More articles from Awards Funding:

nachricht CRTD receives 1.56 Mill. Euro BMBF-funding for retinal disease research
24.05.2017 | DFG-Forschungszentrum für Regenerative Therapien TU Dresden

nachricht BMBF funds translational project to improve radiotherapy
10.05.2017 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt

All articles from Awards Funding >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

Im Focus: Using graphene to create quantum bits

In the race to produce a quantum computer, a number of projects are seeking a way to create quantum bits -- or qubits -- that are stable, meaning they are not much affected by changes in their environment. This normally needs highly nonlinear non-dissipative elements capable of functioning at very low temperatures.

In pursuit of this goal, researchers at EPFL's Laboratory of Photonics and Quantum Measurements LPQM (STI/SB), have investigated a nonlinear graphene-based...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

Physicists discover mechanism behind granular capillary effect

24.05.2017 | Physics and Astronomy

Measured for the first time: Direction of light waves changed by quantum effect

24.05.2017 | Physics and Astronomy

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

VideoLinks
B2B-VideoLinks
More VideoLinks >>>